(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1344327 155230825 (-)-epigallocatechin 3-gallate inhibits the reaction [angiotensin II decreases expression of MYOCD protein in vascular smooth muscle cell] RGD 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of MYOCD mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MYOCD mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MYOCD mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MYOCD promoter] CTD PMID:17942748 , PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:631347 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYOCD mRNA CTD PMID:33387578 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MYOCD mRNA CTD PMID:30951980 aflatoxin B1 increases methylation ISO RGD:1344327 6480464 Aflatoxin B1 results in increased methylation of MYOCD gene CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:1344327 6480464 aflatoxin B2 results in increased methylation of MYOCD intron CTD PMID:30157460 ammonium chloride affects expression ISO RGD:631347 6480464 Ammonium Chloride affects the expression of MYOCD mRNA CTD PMID:16483693 angiotensin II decreases expression ISO RGD:1344327 155230825 angiotensin II decreases expression of MYOCD mRNA and protein in vascular smooth muscle cell RGD arsane affects methylation ISO RGD:1344327 6480464 Arsenic affects the methylation of MYOCD gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1344327 6480464 Arsenic affects the methylation of MYOCD gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:1344327 6480464 Arsenic Trioxide results in increased expression of MYOCD mRNA CTD PMID:26705709 benzo[a]pyrene multiple interactions EXP 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MYOCD mRNA], Benzo(a)pyrene promotes the reaction [AHR protein binds to MYOCD promoter] CTD PMID:19654925 , PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:1344327 6480464 Benzo(a)pyrene affects the methylation of MYOCD intron, Benzo(a)pyrene affects the methylation of MYOCD promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1344327 6480464 Benzo(a)pyrene results in increased methylation of MYOCD 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1344327 6480464 Benzo(a)pyrene results in decreased expression of MYOCD mRNA CTD PMID:22178795 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of MYOCD mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1344327 6480464 Benzo(a)pyrene results in increased expression of MYOCD mRNA CTD PMID:22316170 , PMID:32234424 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1344327 6480464 7 more ... CTD PMID:20382639 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:631347 6480464 Diethylhexyl Phthalate results in decreased expression of MYOCD mRNA CTD PMID:26472102 bisphenol A multiple interactions ISO RGD:631347 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of MYOCD mRNA CTD PMID:26496021 bisphenol A decreases methylation ISO RGD:1344327 6480464 bisphenol A results in decreased methylation of MYOCD gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MYOCD mRNA CTD PMID:30951980 bisphenol A decreases expression ISO RGD:1344327 6480464 bisphenol A results in decreased expression of MYOCD mRNA CTD PMID:27685785 bisphenol A decreases expression ISO RGD:631347 6480464 bisphenol A results in decreased expression of MYOCD mRNA CTD PMID:25181051 more ... bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of MYOCD mRNA CTD PMID:30951980 Butylbenzyl phthalate decreases expression ISO RGD:631347 6480464 butylbenzyl phthalate results in decreased expression of MYOCD mRNA CTD PMID:26472102 cadmium atom multiple interactions ISO RGD:1344327 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MYOCD mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1344327 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MYOCD mRNA CTD PMID:35301059 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1344327 6480464 Nanotubes, Carbon results in increased expression of MYOCD mRNA CTD PMID:31047983 cisplatin multiple interactions ISO RGD:1344327 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of MYOCD mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1344327 6480464 Cisplatin results in decreased expression of MYOCD mRNA CTD PMID:27392435 crocidolite asbestos decreases expression ISO RGD:1344327 6480464 Asbestos, Crocidolite results in decreased expression of MYOCD mRNA CTD PMID:18687144 cyclosporin A affects expression ISO RGD:1344327 6480464 Cyclosporine affects the expression of MYOCD mRNA CTD PMID:33631201 diarsenic trioxide increases expression ISO RGD:1344327 6480464 Arsenic Trioxide results in increased expression of MYOCD mRNA CTD PMID:26705709 dibutyl phthalate decreases expression ISO RGD:631347 6480464 Dibutyl Phthalate results in decreased expression of MYOCD mRNA CTD PMID:26472102 diethyl phthalate decreases expression ISO RGD:631347 6480464 diethyl phthalate results in decreased expression of MYOCD mRNA CTD PMID:26472102 Dimethyl phthalate decreases expression ISO RGD:631347 6480464 dimethyl phthalate results in decreased expression of MYOCD mRNA CTD PMID:26472102 dipentyl phthalate decreases expression ISO RGD:631347 6480464 di-n-pentyl phthalate results in decreased expression of MYOCD mRNA CTD PMID:26472102 dorsomorphin multiple interactions ISO RGD:1344327 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:631347 6480464 paeonol affects the reaction [Doxorubicin results in decreased expression of MYOCD mRNA] CTD PMID:31307187 doxorubicin decreases expression ISO RGD:1344327 6480464 Doxorubicin results in decreased expression of MYOCD mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:631347 6480464 Doxorubicin results in decreased expression of MYOCD mRNA CTD PMID:31307187 entinostat decreases expression ISO RGD:1344327 6480464 entinostat results in decreased expression of MYOCD mRNA CTD PMID:27188386 fonofos increases methylation ISO RGD:1344327 6480464 Fonofos results in increased methylation of MYOCD promoter CTD PMID:22847954 formaldehyde increases expression ISO RGD:1344327 6480464 Formaldehyde results in increased expression of MYOCD mRNA CTD PMID:28937961 furan increases methylation ISO RGD:631347 6480464 furan results in increased methylation of MYOCD gene CTD PMID:22079235 geldanamycin increases expression ISO RGD:1344327 6480464 geldanamycin results in increased expression of MYOCD mRNA CTD PMID:26705709 genistein increases expression EXP 6480464 Genistein results in increased expression of MYOCD mRNA CTD PMID:32186404 gentamycin decreases expression ISO RGD:631347 6480464 Gentamicins results in decreased expression of MYOCD mRNA CTD PMID:33387578 nickel atom decreases expression ISO RGD:1344327 6480464 Nickel results in decreased expression of MYOCD mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression ISO RGD:1344327 6480464 nickel sulfate results in increased expression of MYOCD mRNA CTD PMID:22714537 nitrofen decreases expression ISO RGD:631347 6480464 nitrofen results in decreased expression of MYOCD mRNA CTD PMID:33484710 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MYOCD mRNA CTD PMID:34911549 Paeonol increases expression ISO RGD:631347 6480464 paeonol results in increased expression of MYOCD mRNA CTD PMID:31307187 Paeonol multiple interactions ISO RGD:631347 6480464 paeonol affects the reaction [Doxorubicin results in decreased expression of MYOCD mRNA] CTD PMID:31307187 panobinostat increases expression ISO RGD:1344327 6480464 panobinostat results in increased expression of MYOCD mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1344327 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYOCD mRNA CTD PMID:27188386 parathion increases methylation ISO RGD:1344327 6480464 Parathion results in increased methylation of MYOCD promoter CTD PMID:22847954 phenylephrine multiple interactions ISO RGD:631347 6480464 MYOCD protein affects the reaction [Phenylephrine results in increased expression of ACTA2 mRNA] more ... CTD PMID:14676212 , PMID:16556869 phenylephrine increases expression ISO RGD:631347 6480464 Phenylephrine results in increased expression of MYOCD mRNA, Phenylephrine results in increased expression of MYOCD protein CTD PMID:16556869 phenylmercury acetate increases expression ISO RGD:1344327 6480464 Phenylmercuric Acetate results in increased expression of MYOCD mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1344327 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYOCD mRNA CTD PMID:27188386 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of MYOCD mRNA CTD PMID:16985257 progesterone increases expression ISO RGD:1344327 6480464 Progesterone results in increased expression of MYOCD mRNA CTD PMID:20864642 resveratrol decreases expression ISO RGD:631347 6480464 resveratrol results in decreased expression of MYOCD mRNA CTD PMID:20797428 SB 203580 multiple interactions ISO RGD:1344327 6480464 SB 203580 inhibits the reaction [TGFB1 protein results in increased expression of MYOCD mRNA] CTD PMID:21712382 SB 431542 multiple interactions ISO RGD:1344327 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of MYOCD mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:1344327 6480464 sodium arsenite results in decreased expression of MYOCD mRNA CTD PMID:34032870 sulforaphane decreases expression ISO RGD:1344327 6480464 sulforaphane results in decreased expression of MYOCD mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1344327 6480464 Sunitinib results in decreased expression of MYOCD mRNA CTD PMID:31533062 terbufos increases methylation ISO RGD:1344327 6480464 terbufos results in increased methylation of MYOCD promoter CTD PMID:22847954 testosterone multiple interactions ISO RGD:631347 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of MYOCD mRNA CTD PMID:26496021 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of MYOCD mRNA CTD PMID:23557971 trichloroethene increases methylation ISO RGD:631347 6480464 Trichloroethylene results in increased methylation of MYOCD gene CTD PMID:27618143 trichloroethene decreases expression ISO RGD:631347 6480464 Trichloroethylene results in decreased expression of MYOCD mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1344327 6480464 trichostatin A results in increased expression of MYOCD mRNA CTD PMID:24935251 , PMID:26705709 triclosan decreases expression ISO RGD:1344327 6480464 Triclosan results in decreased expression of MYOCD mRNA CTD PMID:30510588 UTP multiple interactions ISO RGD:631347 6480464 Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of MYL2 protein], Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of NPPA protein] CTD PMID:14676212 valproic acid affects expression ISO RGD:1344327 6480464 Valproic Acid affects the expression of MYOCD mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:631347 6480464 Valproic Acid results in decreased expression of MYOCD mRNA CTD PMID:35594946 valproic acid increases expression ISO RGD:1344327 6480464 Valproic Acid results in increased expression of MYOCD mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1344327 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYOCD mRNA CTD PMID:27188386 XL147 multiple interactions EXP 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOCD mRNA CTD PMID:27935865